VideoHIVINTEREST 2020Cost-Utility Analysis of Dolutegravir-Versus Efavirenz 400mg- Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon: 96-week Results from the NAMSAL ANRS 12313 Trial - Marwan al Qays BousmahView Video
VideoHIVINTEREST 2020What Shapes Resilience Among People Living with HIV? A Multi-Country Analysis of... - Stella KentusiView Video
VideoHIVINTEREST 2020Q&A Symposium 1 - Johnson & Johnson - Innovations in the prevention and treatmentView Video
VideoHIVINTEREST 2020Impact of COVID-19 on HIV, Tuberculosis, and Malaria Epidemiology and Treatment Services Across Africa - John NkengasongView Video
HLHongzhou LuMD, PhDVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Prevalence of HIV/Hep B/C and HIV/TB Co-Infection in China and Neighboring Countries - Hongzhou Lu, MD, PhDView Video
YSYinzhong ShenMDVideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021Caring for the Patient with HIV and TB Co-Infection - Yinzhong Shen, MDView Video
VideoHIVChinese HIV Clinical Forum Educational Series 2020 - 2021COVID-19 in HIV Patients - Lianguo Ruan, MDView Video
